Business

Business: Moderna's Cancer Vaccine Trial Results

Updated 2026-10-21 15:05 UTC 1 source Neutral

Moderna is set to release Phase 3 trial results for its cancer vaccine. The company has been a key player in the biotech sector this year, and the data could significantly impact stock performance.

Coverage timeline — 1 article

MarketWatch

Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.

Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.

2026-10-21 15:00 UTC